AAKP HealthLine Innovator - Increasing Diversity in Clinical Trials: The FINE-ONE Study

Are you, or someone you know, living with type 1 diabetes (T1D) and chronic kidney disease (CKD)? Watch this AAKP HealthLine Innovator webinar focused on diabetic kidney disease management and current research underway, through the FINE-ONE study, which is investigating an innovative treatment aimed at delaying CKD progression in individual with type 1 diabetes.

Help shape the future of kidney patient care by learning how you can get involved in clinical trials and how you can also share these opportunities within your own community.

Moderator:
Jerome Bailey
Director of Patient Engagement and Advocacy
American Association of Kidney Patients

Speakers:
Sylvia Rosas, MD, MSCE
Associate Professor of Medicine
Joslin Diabetes Center
Harvard Medical Scholl

Paul T. Conway
AAKP Chair of Policy and Global Affairs
Former dialysis patient, Current transplant recipient

As the oldest and largest, independent kidney patient organization in the U.S. – AAKP is dedicated to improving the lives and long-term outcomes of kidney patients through education, advocacy, patient engagement, and the fostering of patient communities. AAKP fights for early disease detection and the appropriate diagnosis of rare/genetic conditions; increased kidney transplantation and pre-emptive transplantation; full patient choice of either in-center or home dialysis; protection of the patient/physician relationship; promotion of research and innovation including artificial implantable and wearable kidneys; and the elimination of barriers for patient access to available treatment options. Learn more at www.aakp.org.